This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Intervet Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Joseph Koumans: Innovator in Vaccine Development
Introduction
Joseph Koumans is a notable inventor based in Wageningen, Netherlands. He has made significant contributions to the field of vaccine development, particularly focusing on the treatment of diseases caused by intracellular pathogens in animals.
Latest Patents
Joseph Koumans holds a patent for a serum-free intracellular pathogen vaccine. This innovative vaccine composition comprises a virus antigen with less than 5% serum. The vaccine is designed to reduce, prevent, or avoid cross-stitch spinal deformity in treated animals. Specifically, it is applicable for use in fish, targeting pathogens such as the salmon alpha virus (SAV).
Career Highlights
Throughout his career, Koumans has demonstrated a commitment to advancing veterinary medicine. His work has focused on creating effective vaccine solutions that address critical health issues in animals, particularly in aquaculture.
Collaborations
Joseph Koumans collaborates with esteemed colleagues, including Petter Frost and Maria Forlenza. Their combined expertise contributes to the development of innovative solutions in the field of veterinary vaccines.
Conclusion
Joseph Koumans is a pioneering inventor whose work in vaccine development has the potential to significantly impact animal health. His contributions, particularly in creating a serum-free vaccine for intracellular pathogens, highlight the importance of innovation in veterinary medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile